Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1970 Jun 1;131(6):1121–1136. doi: 10.1084/jem.131.6.1121

AUGMENTATION OF THE VIRULENCE OF MURINE COXSACKIE-VIRUS B-3 MYOCARDIOPATHY BY EXERCISE

Bienvenido G Gatmaitan 1, Jacob L Chason 1, A Martin Lerner 1
PMCID: PMC2138852  PMID: 4246139

Abstract

Coxsackievirus B-3 myocardiopathy was induced in weanling mice by intraperitoneal and intracerebral inoculations of the Nancy strain. Acute mortality was 5.5%. The cardiomyopathy is characterized by an early phase lasting about 9 days with myocardial necrosis, associated inflammation, and healing by fibrosis and calcification involving 25 to 50% of the contractile fibers in each affected mouse. Infectious coxsackievirus may be recovered from the heart during this phase. Continuing myocardial inflammatory lesions follow during the later phase, but infectious virus is no longer present. When mice were forced to swim in a preheated pool (33°C) during both phases of their myocardiopathy, virulence was strikingly augmented. Fully half of the mice died of congestive failure, the majority while swimming. Hearts were dilated, hypertrophied, and grossly necrotic. The myocardium was transformed to a completely necrotic, inflammatory, calcifying mass. At the peak of the infectious phase, myocardial replication of coxsackievirus was increased 530 times in nurslings which had been forced to swim. Myositis in hind limbs was more frequent, and inflammatory lesions in perirenal and pericardial fat were more severe in the mice which were forced to swim. When swimming was begun on the 9th day after infection, the virulence and lethality (13.8%) of infection were moderately increased.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORING W. D., WALKER D. L., ZU RHEIN G. M. Factors influencing host-virus interactions. II. Alteration of Coxsackie virus infection in adult mice by cold. Proc Soc Exp Biol Med. 1956 Nov;93(2):273–277. doi: 10.3181/00379727-93-22730. [DOI] [PubMed] [Google Scholar]
  2. FEDERICI E. E., LERNER A. M., ABELMANN W. H. Observations on the course of Coxsackie A-9 myocarditis in C3H mice. Proc Soc Exp Biol Med. 1963 Mar;112:672–676. doi: 10.3181/00379727-112-28136. [DOI] [PubMed] [Google Scholar]
  3. GRODUMS E. I., DEMPSTER G. Myocarditis in experimental Coxsackie B-3 infection. Can J Microbiol. 1959 Dec;5:605–615. doi: 10.1139/m59-074. [DOI] [PubMed] [Google Scholar]
  4. GRODUMS E. I., DEMPSTER G., SPENCER W. A. Experimental Coxsackie group B virus infections. Arch Gesamte Virusforsch. 1963;13:160–166. doi: 10.1007/BF01243837. [DOI] [PubMed] [Google Scholar]
  5. GRODUMS E. I., DEMPSTER G. The age factor in experimental Coxsackie B-3 infection. Can J Microbiol. 1959 Dec;5:595–604. doi: 10.1139/m59-073. [DOI] [PubMed] [Google Scholar]
  6. HORSTMANN D. M. Acute poliomyelitis relation of physical activity at the time of onset to the course of the disease. J Am Med Assoc. 1950 Jan 28;142(4):236–241. doi: 10.1001/jama.1950.02910220016004. [DOI] [PubMed] [Google Scholar]
  7. KILBOURNE E. D., WILSON C. B., PERRIER D. The induction of gross myocardial lesions by a Coxsackie (pleurodynia) virus and cortisone. J Clin Invest. 1956 Apr;35(4):362–370. doi: 10.1172/JCI103286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LERNER A. M., LEVIN H. S., FINLAND M. Age and susceptibility of mice to Coxsackie A viruses. J Exp Med. 1962 Apr 1;115:745–762. doi: 10.1084/jem.115.4.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. LERNER A. M., SHAKA J. A. Coxsackie A9 myocarditis in adult mice. Proc Soc Exp Biol Med. 1962 Dec;111:804–808. doi: 10.3181/00379727-111-27927. [DOI] [PubMed] [Google Scholar]
  10. Lerner A. M. An experimental approach to virus myocarditis. Prog Med Virol. 1965;7:97–115. [PubMed] [Google Scholar]
  11. Lerner A. M. Coxsackievirus myocardiopathy. J Infect Dis. 1969 Oct;120(4):496–499. doi: 10.1093/infdis/120.4.496. [DOI] [PubMed] [Google Scholar]
  12. Lerner A. M. Virus myopericarditis. Ann Intern Med. 1968 Nov;69(5):1068–1070. doi: 10.7326/0003-4819-69-5-1068. [DOI] [PubMed] [Google Scholar]
  13. ROSENBAUM H. E., HARFORD C. G. Effect of fatigue on susceptibility of mice to poliomyelitis. Proc Soc Exp Biol Med. 1953 Aug-Sep;83(4):678–681. doi: 10.3181/00379727-83-20456. [DOI] [PubMed] [Google Scholar]
  14. TILLES J. G., ELSON S. H., SHAKA J. A., ABELMANN W. H., LERNER A. M., FINLAND M. EFFECTS OF EXERCISE ON COXSACKIE A9 MYOCARDITIS IN ADULT MICE. Proc Soc Exp Biol Med. 1964 Dec;117:777–782. doi: 10.3181/00379727-117-29696. [DOI] [PubMed] [Google Scholar]
  15. WILSON F. M., HASHIMI A., LERNER A. M. MULTIPLICATION OF BOSTON STRAINS OF COXSACKIEVIRUS A9 IN THE ADULT MOUSE HEART. J Bacteriol. 1965 Aug;90:546–548. doi: 10.1128/jb.90.2.546-548.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wilson F. M., Miranda Q. R., Chason J. L., Lerner A. M. Residual pathologic changes following murine coxsackie A and B myocarditis. Am J Pathol. 1969 May;55(2):253–265. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES